MORGAN STANLEY PLC/CALL/FRESENIUS/45/0.1/20.12.24 Share Price

Warrant

DE000MB9SVP9

Market Closed - Börse Stuttgart 10:23:01 11/06/2024 pm IST
0.014 EUR -12.50% Intraday chart for MORGAN STANLEY PLC/CALL/FRESENIUS/45/0.1/20.12.24
1 month-20.00%
3 months+45.45%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
11/24/11 0.014 -12.50%
10/24/10 0.016 -11.11%
07/24/07 0.018 0.00%
06/24/06 0.018 +12.50%
05/24/05 0.016 +6.67%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 10:23 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Morgan Stanley
WKN MB9SVP
ISINDE000MB9SVP9
Date issued 15/08/2023
Strike 45
Maturity 20/12/2024 (192 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.124
Lowest since issue 0.001
Delta0.08x
Omega 9.098
Premium53.82x
Gearing109x
Moneyness 0.6540
Difference Strike 15.57
Difference Strike %+34.60%
Spread 0.026
Spread %65.00%
Theoretical value 0.0270
Implied Volatility 36.79 %
Total Loss Probability 95.04 %
Intrinsic value 0.000000
Present value 0.0270
Break even 45.27 €
Theta-0x
Vega0x
Rho0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.43 EUR
Average target price
37.26 EUR
Spread / Average Target
+26.59%
Consensus